Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron,

     Healthcare Companies Report Stock Price Updates, and Medical System
      Integration - Research Report on Johnson & Johnson, Geron, Ligand
              Pharmaceuticals, Masimo, and Capital Senior Living

PR Newswire

NEW YORK, December 10, 2013

NEW YORK, December 10, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Johnson &
Johnson (NYSE: JNJ), Geron Corporation (NASDAQ: GERN), Ligand Pharmaceuticals
Inc. (NASDAQ: LGND), Masimo Corporation (NASDAQ: MASI), and Capital Senior
Living Corp. (NYSE: CSU). Today's readers may access these reports free of
charge - including full price targets, industry analysis and analyst ratings -
via the links below.

Johnson & Johnson Research Report

On December 5, 2013, Johnson & Johnson's stock ended the day's trading at
$92.97, reflecting a decrease of 0.70% from the previous closing price. The
Company's stock edged down by 1.39% over the past three trading days, compared
to the Dow Jones Industrial Average Index which ended 1.17% lower during the
same trading period. The Full Research Report on Johnson & Johnson - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.analystscorner.com/r/full_research_report/07a8_JNJ

--

Geron Corporation Research Report

On December 5, 2013, Geron Corporation's (Geron) stock gained 2.26% as it
closed the day's trading session at $5.87. For the past three trading days,
the Company's stock increased 2.44%, compared to the Dow Jones Industrial
Average Index which ended 1.17% lower over the same three trading days. The
Full Research Report on Geron Corporation - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

http://www.analystscorner.com/r/full_research_report/1ca9_GERN

--

Ligand Pharmaceuticals Inc. Research Report

On December 5, 2013, Ligand Pharmaceuticals Inc.'s (Ligand Pharmaceuticals)
stock increased 2.52%, closing the day's trading at $56.52. The Company's
stock, however, declined 0.16% over the past three trading days, compared to
the Nasdaq Composite Index which ended 0.30% lower during the same trading
period. The Full Research Report on Ligand Pharmaceuticals Inc. - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.analystscorner.com/r/full_research_report/3b8d_LGND

--

Masimo Corporation Research Report

On November 22, 2013, Masimo Corporation (Masimo) announced that ACUTRONIC
Medical Systems AG has integrated Masimo SET® Measure-through Motion and Low
Perfusion™ pulse oximetry into ACUTRONIC's fabian HFO Neonatal Critical Care
Ventilator for improved patient outcomes. According to the Company, the
combined technology platform will optimize patient assessments and improve
workflow, which allows clinicians to spend more time tending to patients.
Masimo's President of Worldwide OEM Business & Corporate Development, Rick
Fishel, stated, "The synergies realized between our companies and products
support Masimo's mission to improve patient outcomes and reduce the cost of
care by taking noninvasive monitoring to new sites and applications. We are
very pleased that Masimo's SET® Pulse Oximetry platform is a key component in
ACUTRONIC's new neonatal ventilators." The Full Research Report on Masimo
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/6e22_MASI

--

Capital Senior Living Corp. Research Report

On December 5, 2013, Capital Senior Living Corp.'s (Capital Senior Living)
stock gained 4.55%, closing the day's trading at $23.42. For the past three
trading days, the Company's stock increased 4.46%, compared to the Dow Jones
Industrial Average Index which ended 1.17% lower over the same trading period.
The Full Research Report on Capital Senior Living Corp. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.analystscorner.com/r/full_research_report/ca95_CSU

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://AnalystsCorner.com



SOURCE Analysts' Corner

Contact: Joe Thomas, CONTACT PHONE: +1-310-496-8071 (North America)